Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Misdiagnosed with CLL in 2012. Remained in watch and wait until 2014 when I became sick, oncologist strongly recommended the go-to CLL chemotherapy. Something told me to get a second opinion, so I found the CLL specialist Dr. Clive Zent at the Wilmot Cancer Center in the U of R in Rochester NY. After a complete exam, slew of bloodwork and a bone marrow biopsy, I was diagnosed with an extremely rare subset of a rare non- Hodgkins Lymphoma called Lymphoplasmacytic Lymphoma (LPL), very similar to Waldenstroms Macroglobulenemia. I started on a BTK Inhibutor (Immunotherapy) called Ibrutinub. Once stable, I maintained great numbers with some side effects. Most side effects were manageable except the mouth sores and Thrush. After extensive research, I decided to seek a newer BTK Inhibitor called Zanubrutinib (Brukinsa) and better care from advice of a friend, and ended up at Roswell Cancer Institute in Buffalo NY. I have been on Zanubrutinib for about three months now and doing good so far. I still have some side effects, however no horrible mouth sores or Thrush. I go see my local oncologist Dr Rahul Seth of the Upstate Cancer Center of Syracuse’s satellite office located in the Oswego NY Hospital for a follow up and results of a large amount of bloodwork that he ordered. I remain positive about my future.